文献速递骨肌MR

体外软骨细胞长期暴露于高剂量Gd-DTPA及新型软骨靶向MR对比剂后的毒性研究

In vitro chondrocyte toxicity following long-term, high-dose exposure to Gd-DTPA and a novel cartilage-targeted MR contrast agent.
PubMed 文献 · Skeletal Radiol · 2016-11-04

本研究在长期培养的Swarm大鼠软骨肉瘤软骨细胞样细胞系中,比较了软骨靶向对比剂DAB4-DLN柠檬酸盐与Gd-DTPA(1.0–20 mM暴露48小时)的毒性;两种对比剂在≤7.5 mM(约为关节造影常用剂量的3倍)时对细胞增殖影响极小,支持该剂量范围可用于MR关节造影。

要点

  • DAB4-DLN柠檬酸盐与Gd-DTPA在1.0–7.5 mM浓度下暴露48小时对软骨细胞增殖影响极小。
  • 更高浓度时两种对比剂均出现剂量依赖性软骨细胞数量下降,DAB4-DLN柠檬酸盐在更低剂量即出现DNA含量和钙黄绿素荧光下降。
  • 两种对比剂均引起剂量依赖性MTT染色(细胞代谢)下降,DAB4-DLN柠檬酸盐在更低剂量即表现更明显效应。

核心结论

  • 模型软骨细胞培养长期暴露于≤7.5 mM(约为关节造影常用剂量的3倍)的DAB4-DLN柠檬酸盐和Gd-DTPA时影响极小,支持该剂量范围可用于MR关节造影,且实验暴露持续时间远长于临床使用。

研究设计与样本

  • 体外研究,采用长期培养的Swarm大鼠软骨肉瘤软骨细胞样细胞系,暴露48小时于1.0–20 mM的DAB4-DLN柠檬酸盐、1.0–20 mM Gd-DTPA、1.0 μM星形孢菌素(阳性对照)或不予处理,比较细胞形态、MTT代谢活性、PicoGreen DNA含量和钙黄绿素-AM活力。

诊断标准与关键数值

  • 1.0–7.5 mM浓度下两种对比剂对细胞增殖仅有极小下降。
  • 所有剂量下两种对比剂处理24小时后细胞培养形态相似。
  • 更高剂量处理48小时后出现细胞培养形态差异,两种对比剂均呈剂量依赖性软骨细胞数量下降。
  • 48小时处理后DNA含量和钙黄绿素荧光呈浓度依赖性下降,但DAB4-DLN柠檬酸盐开始下降的剂量低于Gd-DTPA。
  • 两种对比剂均引起剂量依赖性MTT染色下降,DAB4-DLN柠檬酸盐在更低剂量即出现更大效应;20 mM DAB4-DLN柠檬酸盐处理48小时细胞MTT染色差,可能提示细胞死亡或濒死。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To determine the concentrations exhibiting toxicity of a cartilage-targeted magnetic resonance imaging contrast agent compared with gadopentetate dimeglumine (Gd-DT-PA) in chondrocyte cultures.

MATERIALS AND METHODS: A long-term Swarm rat chondrosarcoma chondrocyte-like cell line was exposed for 48 h to 1.0-20 mM concentrations of diaminobutyl-linked nitroxide (DAB4-DLN) citrate, 1.0-20 mM Gd-DTPA, 1.0 μM staurosporine (positive control), or left untreated. Cell appearance, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays of metabolic activity, quantitative PicoGreen assays of DNA content, and calcein-AM viability assays were compared.

RESULTS: At 1.0-7.5 mM, minimal decrease in cell proliferation was found for both agents. At all doses of both agents, cell culture appearances were similar after 24 h of treatment. At the higher doses, differences in cell culture appearance were found after 48 h of treatment, with dose-dependent declines in chondrocyte populations for both agents. Concentration-dependent declines in DNA content and calcein fluorescence were found after 48 h of treatment, but beginning at a lower dose of DAB4-DLN citrate than Gd-DTPA. Dose-dependent decreases in MTT staining (cell metabolism) were apparent for both agents, but larger effects were evident at a lower dose for DAB-DLN citrate. Poor MTT staining of cells exposed for 48 h to 20 mM DAB4-DLN citrate probably indicates dead or dying cells.

CONCLUSION: The minimal effect of the long-term exposure of model chondrocyte cell cultures to DAB4-DLN citrate and Gd-DTPA concentrations up to 7.5 mM (3x typical arthrographic administration) is supporting evidence that these doses are acceptable for MR arthrography. The findings are reassuring given that the experimental exposure to the contrast agents at sustained concentrations was much longer than when used clinically.

来源:Skeletal Radiol,查看原文。版权归原作者所有。

引用

  1. Midura S, Schneider E, Rosen GM, et al. In vitro chondrocyte toxicity following long-term, high-dose exposure to Gd-DTPA and a novel cartilage-targeted MR contrast agent. Skeletal Radiol. 2016. PMID: 27815598

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。